期刊
SENSORS AND ACTUATORS B-CHEMICAL
卷 401, 期 -, 页码 -出版社
ELSEVIER SCIENCE SA
DOI: 10.1016/j.snb.2023.135023
关键词
Electrocatalyst; Electrochemical sensor; Prostate cancer; Flutamide; Nonsteroidal anticancer drug
In recent years, there has been an increase in the number of patients with prostate cancer, leading to a greater need for monitoring and detecting the anticancer drug, flutamide, in the human body. Researchers have developed a novel electrocatalyst based on Alg-Cys-AuNPs for the detection of flutamide, which exhibits excellent detection performance and is suitable for real-time industrial applications.
In recent years, the number of patients with prostate cancer has increased in many countries. Consequently, the use of anticancer drugs to effective cancer treatment has also risen. Flutamide (FLU) is an anticancer drug that can cause significant side effects when the dose is too high. Therefore, there is an urgent need to monitor and detect this drug in the human body. In this regard, we have developed a novel electrocatalyst based on Alg-Cys-AuNPs for FLU detection. This functionalization creates more active sites, increasing the surface area and electron transportation, resulting in an excellent detection limit (LOD; 1.4 nM), linear range (LR; 0.001-5.23 mu M), and sensitivity (65.99 ( +/- 0.002) mu A mu M-1 cm(-2)) for FLU. Furthermore, the proposed electrocatalyst FLU sensor has demonstrated good repeatability, anti-interference capabilities, stability, and real-time analysis with satisfactory recovery results. This clearly indicates its suitability for real-time industrial applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据